Girihlet
OverviewSuggest Edit
Girihlet is a biotechnology company that uses T-cell sequencing for immune system monitoring. It offers a platform aimed at accelerating the discovery of disease-monitoring and therapeutic strategies for immune diseases. The company provides TCR, mtDNA, RNA, whole exome/ targeted genome, microbiome, and HLA sequencing services.
| Type | Private | |
| Founded | 2012 | |
| Website | girihlet.com |
Latest Updates
| Employees (est.) (Jan 2021) | 3 | |
| Cybersecurity rating | C | More |
Girihlet Financials and Metrics
Summary Metrics
Founding Date | 2012 |
Girihlet total Funding | $2.8 m |
Girihlet latest funding size | $2.50 m |
Time since last funding | 2 years ago |
Girihlet investors | True Ventures, Digitalis Ventures |
Girihlet's latest funding round in August 2018 was reported to be $2.5 m. In total, Girihlet has raised $2.8 m
Girihlet Cybersecurity Score
Girihlet Online and Social Media Presence
180 Twitter followers
Girihlet has 180 Twitter Followers. The number of followers has decreased 0.7% month over month and decreased 0.1% quarter over quarter
Girihlet's Trends
Twitter Engagement Stats for @girihlet
97
Tweets
172
Following
180
Followers
1
Tweets last 30 days
0
Avg. likes per Tweet
100%
Tweets with engagement
Girihlet Frequently Asked Questions
When was Girihlet founded?
Girihlet was founded in 2012.
How many employees does Girihlet have?
Girihlet has 3 employees.
Who are Girihlet competitors?
Competitors of Girihlet include Genisphere, Ring Therapeutics and Trucode Gene Repair.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies